DAXXIFY is the first and only peptide-formulated neuromodulator - instead of the human blood-derived stabilizer traditional neuromodulators use, it's built around a custom peptide, with results that patients and Dr. Kamangar can discuss as an alternative to traditional options. In clinical studies, more than half of patients still had none or only mild frown lines at 6 months, with onset as early as day 1.